| Revenue | 284.42a | 258.41a |
| Cost of revenue | -245.52a | -225.78a |
| Gross profit | 38.9a | 32.63a |
| Selling and marketing expenses | -3.1a | -2.99a |
| General and administrative expenses | -18.73a | -17.77a |
| Research and development expenses | -2.53a | -2.29a |
| Net (impairment losses)/reversal of impairment losses on financial assets and contract assets | -0.27a | 0.03a |
| Other income | 0.99a | 2.28a |
| Other gains, net | 0.37a | 0.41a |
| Operating profit | 15.62a | 12.31a |
| Finance income | 0.62a | 0.63a |
| Finance costs | -2.37a | -2.27a |
| Finance costs, net | -1.76a | -1.64a |
| Share of loss of associates and joint ventures, net | -0.07a | -0.07a |
| Impairment provision for investments in associates and joint ventures | -0.19a | -0.12a |
| Profit before income tax | 13.61a | 10.49a |
| Income tax expense | -3.39a | -2.57a |
| Profit for the year | 10.22a | 7.91a |
| Attributable to: | — | — |
| Owners of the Company | 10.17a | 8.23a |
| Non-controlling interests | 0.05a | -0.32a |